Literature DB >> 22122359

Severe coagulopathy caused by rifampicin in patients with primary sclerosing cholangitis and refractory pruritus.

Fotios Sampaziotis, William J H Griffiths.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22122359      PMCID: PMC3403211          DOI: 10.1111/j.1365-2125.2011.04158.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  13 in total

Review 1.  Antibiotic-associated hypoprothrombinemia: a review of prospective studies, 1966-1988.

Authors:  Y M Shevchuk; J M Conly
Journal:  Rev Infect Dis       Date:  1990 Nov-Dec

2.  Haemorrhagic disease of the newborn in the offspring of rifampicin and isoniazid treated mothers.

Authors:  E Eggermont; N Logghe; W Van De Casseye; M Casteels-Van Daele; J Jaeken; J Cosemans; M Verstraete; M Renaer
Journal:  Acta Paediatr Belg       Date:  1976 Apr-Jun

3.  [Vitamin K deficiency syndrome caused by antituberculous agents].

Authors:  F Ishii; B Iizuka; T Nakanishi; K Nagasako; N Hayashi
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  1997-06

Review 4.  Pathophysiology and current management of pruritus in liver disease.

Authors:  Andreas E Kremer; Ronald P J Oude Elferink; Ulrich Beuers
Journal:  Clin Res Hepatol Gastroenterol       Date:  2011-02       Impact factor: 2.947

Review 5.  The efficacy and safety of bile Acid binding agents, opioid antagonists, or rifampin in the treatment of cholestasis-associated pruritus.

Authors:  Puneeta Tandon; Brian H Rowe; Ben Vandermeer; Vincent G Bain
Journal:  Am J Gastroenterol       Date:  2007-03-31       Impact factor: 10.864

6.  Cerebral hemorrhage associated with vitamin K deficiency in congenital tuberculosis treated with isoniazid and rifampin.

Authors:  Ken-ichiro Kobayashi; Tsunekazu Haruta; Haruko Maeda; Masaru Kubota; Toshikazu Nishio
Journal:  Pediatr Infect Dis J       Date:  2002-11       Impact factor: 2.129

7.  Hepatitis and liver dysfunction with rifampicin therapy for pruritus in primary biliary cirrhosis.

Authors:  M I Prince; A D Burt; D E J Jones
Journal:  Gut       Date:  2002-03       Impact factor: 23.059

Review 8.  Candidate selection and organ allocation in liver transplantation.

Authors:  Muhammad F Dawwas; Alexander E Gimson
Journal:  Semin Liver Dis       Date:  2009-02-23       Impact factor: 6.115

Review 9.  Pathogenesis and treatment of pruritus in cholestasis.

Authors:  Andreas E Kremer; Ulrich Beuers; Ronald P J Oude-Elferink; Thomas Pusl
Journal:  Drugs       Date:  2008       Impact factor: 9.546

10.  Reversible hypoprothrombinemia in a patient with primary biliary cirrhosis treated with rifampicin.

Authors:  W Van Steenbergen; J Vermylen
Journal:  Am J Gastroenterol       Date:  1995-09       Impact factor: 10.864

View more
  6 in total

1.  A Practical Review of Primary Biliary Cholangitis for the Gastroenterologist.

Authors:  Fernanda Q Onofrio; Gideon M Hirschfield; Aliya F Gulamhusein
Journal:  Gastroenterol Hepatol (N Y)       Date:  2019-03

2.  The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines.

Authors:  Gideon M Hirschfield; Jessica K Dyson; Graeme J M Alexander; Michael H Chapman; Jane Collier; Stefan Hübscher; Imran Patanwala; Stephen P Pereira; Collette Thain; Douglas Thorburn; Dina Tiniakos; Martine Walmsley; George Webster; David E J Jones
Journal:  Gut       Date:  2018-03-28       Impact factor: 23.059

3.  Severe fat-soluble vitamin deficiency suspected secondary to intrahepatic cholestasis of pregnancy: A case report.

Authors:  Minhazur Sarker; Chloe Getrajdman; Leslie Warren; Lauren Ferrara
Journal:  Case Rep Womens Health       Date:  2022-07-09

Review 4.  Novel strategies and therapeutic options for the management of primary biliary cholangitis.

Authors:  Amardeep Khanna; David E Jones
Journal:  Therap Adv Gastroenterol       Date:  2017-09-07       Impact factor: 4.409

5.  Coagulation disorders during treatment with cefazolin and rifampicin: rare but dangerous.

Authors:  Ines Kouki; Clémence Montagner; Wladimir Mauhin; Jonathan London; Thierry Lazard; Sylvie Grimbert; Valérie Zeller; Olivier Lidove
Journal:  J Bone Jt Infect       Date:  2021-04-01

6.  Low risk of hepatotoxicity from rifampicin when used for cholestatic pruritus: a cross-disease cohort study.

Authors:  G J Webb; S R Rahman; C Levy; G M Hirschfield
Journal:  Aliment Pharmacol Ther       Date:  2018-02-22       Impact factor: 8.171

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.